Portable Nanoplasmonic Imager Detects Sepsis Faster
|
By HospiMedica International staff writers Posted on 05 Feb 2020 |

Image: A nano-scale optical biosensor can rapidly detect sepsis (Photo courtesy of EPFL)
A highly portable device based on a nano-scale optical biosensor can rapidly detect inflammatory biomarkers in a patient's bloodstream.
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







